Package 0430-0979-03

Brand: atelvia

Generic: risedronate sodium
NDC Package

Package Facts

Identity

Package NDC 0430-0979-03
Digits Only 0430097903
Product NDC 0430-0979
Product ID 0430-0979_5a50333a-4e4a-4ca3-806b-ee629efbaa7a
Description

4 TABLET, DELAYED RELEASE in 1 DOSE PACK (0430-0979-03)

Marketing

Marketing Status
Marketed Since 2010-12-01
Brand atelvia
Generic risedronate sodium
Sample Package No

Linked Drug Pages (1)

Atelvia ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "5a50333a-4e4a-4ca3-806b-ee629efbaa7a", "openfda": {"unii": ["HU2YAQ274O", "F67L43UT5C"], "rxcui": ["1020064", "1020065", "1020066"], "spl_set_id": ["c8b9ab88-1a26-46c3-80ec-4eaa45202021"], "manufacturer_name": ["Allergan, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 TABLET, DELAYED RELEASE in 1 DOSE PACK (0430-0979-03)", "package_ndc": "0430-0979-03", "marketing_start_date": "20101201"}], "brand_name": "Atelvia", "product_id": "0430-0979_5a50333a-4e4a-4ca3-806b-ee629efbaa7a", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Bisphosphonate [EPC]", "Bisphosphonate [EPC]", "Diphosphonates [CS]", "Diphosphonates [CS]"], "product_ndc": "0430-0979", "generic_name": "risedronate sodium", "labeler_name": "Allergan, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atelvia", "active_ingredients": [{"name": "RISEDRONATE SODIUM HEMIPENTAHYDRATE", "strength": "30.1 mg/1"}, {"name": "RISEDRONATE SODIUM MONOHYDRATE", "strength": "4.9 mg/1"}], "application_number": "NDA022560", "marketing_category": "NDA", "marketing_start_date": "20101201", "listing_expiration_date": "20271231"}